Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 0 open-market purchases and 9 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Charles River Laboratories International, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 644 | 9 | 629 | −6 |
| Shares | 47.6M | 226.8K | 48.7M | +1.36M (+2.9%) |
| Value | $13.5B | $64.5M | $10.4B | −$3.01B (−22.4%) |
9 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (67)
Institutions that held Charles River Laboratories International, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
Sold out (73)
Institutions that held Charles River Laboratories International, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (9)
Institutions that held Charles River Laboratories International, Inc. at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Parametric Portfolio Associates LLC | 143,111 | $40.6M |
| Kings Point Capital Management | 48,448 | $13.8M |
| Amalgamated Financial Corp. | 19,054 | $5.41M |
| NN Investment Partners Holdings N.V. | 7,445 | $2.11M |
| Lyon Street Capital, LLC | 4,500 | $1.28M |
| Teachers Retirement System of the State of Kentucky | 3,642 | $1.03M |
| PGGM Investments | 623 | $235.0K |
| Lenox Wealth Advisors, LLC | 21 | $6.00K |
| SJS Investment Consulting Inc. | 1 | $0 |